Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2025, 9:33 AM EST

Kiromic BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
01132462
Market Cap Growth
-99.67%26.04%-66.79%-86.04%-61.97%-
Enterprise Value
1313852173
Last Close Price
0.000.900.875.4245.90254.10

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
0.00-0.11-0.12-0.570.875.47
P/TBV Ratio
----0.875.47

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-1.16-1.16-1.70-1.630.020.04
Net Debt / Equity Ratio
-1.07-1.07-1.35-1.52-0.91-0.85
Net Debt / EBITDA Ratio
-0.62-0.62-0.70-0.301.001.01
Net Debt / FCF Ratio
-0.68-0.68-0.58-0.311.121.28
Quick Ratio
0.050.050.160.057.446.92
Current Ratio
0.160.160.220.137.947.32
Return on Equity (ROE)
----322.40%-132.30%-287.84%
Return on Assets (ROA)
-143.47%-143.47%-103.26%-91.09%-72.62%-79.21%
Return on Capital Employed (ROCE)
192.40%192.40%242.90%2364.70%-92.60%-86.30%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-2946496.82%-1949.21%-1913.39%-1053.36%-108.34%-30.91%
FCF Yield
-12626751.59%-1436.58%-1957.51%-868.21%-94.06%-12.21%
Buyback Yield / Dilution
-33.09%-33.09%-101.59%-43.07%-153.38%-57.39%